Advances in botulinum toxin
The global market for non-invasive treatments reached $8.86 billion in 2024 and is expected to climb to $13.78 billion by 2030
Leading the way for non-invasive treatments in the global market is still botulinum toxin
Botulinum toxin is the most performed cosmetic procedure worldwide and has been a staple of aesthetic clinics for almost three decades. Until recently, the market remained relatively stable, with a handful of major players offering toxin products. In the last couple of years, we have seen the introduction of new types of toxins to the market for the first time, and recently, Allergan got the world’s first approval for the use of BOTOX® Cosmetic in moderate to severe vertical bands connecting the jaw and neck (platysma bands).As the market has evolved, use of toxins has become more and more advanced, and 2025 looks also set to welcome some new innovations in this area.
Longer lasting results: New formulations that extend the effect of botulinum toxin from three to four months to six to nine months, which means fewer treatments are required
AI-guided precision: Artificial intelligence will guide practitioners in injecting with more precision, considering each patient’s facial anatomy to create a more natural outcome
New approvals: Previously off-licence uses in the lower face and neck are now receiving approval, such as Allergan’s recent announcement that BOTOX® Cosmetic has been approved by the FDA for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
Needle-free injections: A study published in Annals of Dermatology has found that a needle-free microjet drug injector could be a useful method for treating crow’s feet wrinkles with botulinum toxin due to its ability to reduce pain
Check out our article, Non-invasive procedures: The rise of needle-free enhancements which explores the growing demand for non-invasive procedures and the key needle-free enhancements shaping the future.
